The Board is formed by nine members elected for renewable three-year terms.
In order to guarantee the interests of the different profiles of the members, the board is made up of large, medium and smaller structures.
Our members are legal entities active in the sector of medicines for human use in the Grand Duchy of Luxembourg.
They are also active in the field of preclinical research as well as in all four phases of clinical research. Together they include large international groups, SMEs and startups.
In our mission to promote the best healthcare for the Luxembourg population, we are supported by media and professional partners such as Luxembourg wholesalers and specialized consulting companies.
Together, we share our expertise and support to enable Luxembourg patients to benefit from the industry's therapeutic innovations.
Join us to participate in these challenges.
We rely on our Secretary General and the support of an Office Manager, but also on nearly thirty experts from the innovative pharmaceutical industry.
Together we develop ideas and positions to contribute to therapeutic innovation for Luxembourg patients.
Keep up to date with iml.lu
The flash letter informs you regularlay about the news of our sector in Luxembourg, the news of the research in Luxembourg, within our members and finally about the news of the association. Don't waste a minute and subscribe.